Upon searching the Open Targets platform, we identified 10 known small molecule drugs in clinical trials (including LY2584702) that are linked to two proteins (RPS6KB1 and MMP12), targeting various cancers, chronic hepatitis C infection and chronic obstructive pulmonary disease (Supplementary Table 7). Here, RPS6KB1 is linked to chronic hepatitis C virus infection.